These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36754490)

  • 1. Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes.
    Motairek I; Al-Kindi S
    Endocrinol Metab Clin North Am; 2023 Mar; 52(1):135-147. PubMed ID: 36754490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
    Newman JD; Schwartzbard AZ; Weintraub HS; Goldberg IJ; Berger JS
    J Am Coll Cardiol; 2017 Aug; 70(7):883-893. PubMed ID: 28797359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of cardiovascular disease in patients with diabetes.
    Hudspeth B
    Am J Manag Care; 2018 Aug; 24(13 Suppl):S268-S272. PubMed ID: 30160393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal: The PICT2RE observational study.
    Cardoso H; Tavares Bello C; Andrade L; Sobral do Rosário F; Louro J; Nogueira C; Rodrigues E; Vieira NB; Carqueja T;
    Rev Port Cardiol; 2023 Apr; 42(4):319-330. PubMed ID: 36634764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of cardiovascular disease risk by health behaviour change following type 2 diabetes diagnosis.
    Estlin AFL; Ahern AL; Griffin SJ; Strelitz J
    Diabet Med; 2021 Oct; 38(10):e14646. PubMed ID: 34270827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
    Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
    Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontraditional risk factors for cardiovascular disease in diabetes.
    Fonseca V; Desouza C; Asnani S; Jialal I
    Endocr Rev; 2004 Feb; 25(1):153-75. PubMed ID: 14769830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bariatric surgery versus medical therapy on long-term cardiovascular risk in low BMI Chinese patients with type 2 diabetes: a propensity score-matched analysis.
    Ke Z; Zhou X; Sun F; Li F; Tong W; Zhu Z
    Surg Obes Relat Dis; 2022 Apr; 18(4):475-483. PubMed ID: 34969592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database.
    Meyers J; Hoog M; Mody R; Yu M; Davis K
    Clin Ther; 2021 Nov; 43(11):1827-1842. PubMed ID: 34625283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic implications with newer agents to reduce cardiovascular risk in diabetes.
    McAdam-Marx C
    Am J Manag Care; 2018 Aug; 24(13 Suppl):S279-S285. PubMed ID: 30160395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
    Wright AK; Suarez-Ortegon MF; Read SH; Kontopantelis E; Buchan I; Emsley R; Sattar N; Ashcroft DM; Wild SH; Rutter MK
    Circulation; 2020 Nov; 142(20):1925-1936. PubMed ID: 33196309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.
    Miller RG; Costacou T
    Curr Cardiol Rep; 2022 Oct; 24(10):1467-1475. PubMed ID: 35947333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real-world study of patients followed for up to 19 years.
    Coles B; Zaccardi F; Hvid C; Davies MJ; Khunti K
    Diabetes Obes Metab; 2021 Jan; 23(1):218-227. PubMed ID: 33026165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.
    Yun JS; Ko SH
    Metabolism; 2021 Oct; 123():154838. PubMed ID: 34333002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes. The SEARCH for Diabetes in Youth Study.
    Kim G; Divers J; Fino NF; Dabelea D; Lawrence JM; Reynolds K; Bell RA; Mayer-Davis E; Crume T; Pettitt DJ; Pihoker C; Liu L
    Pediatr Diabetes; 2019 Sep; 20(6):693-701. PubMed ID: 30903717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surgical versus medical therapy on estimated cardiovascular event risk among adolescents with type 2 diabetes and severe obesity.
    Ryder JR; Xu P; Nadeau KJ; Kelsey MM; Xie C; Jenkins T; Inge TH; Bjornstad P
    Surg Obes Relat Dis; 2021 Jan; 17(1):23-33. PubMed ID: 33071178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: a systematic review].
    Hopmans TE; van Houten C; Kasius A; Kouznetsova OI; Nguyen LA; Rooijmans SV; Voormolen DN; van Vliet EO; Franx A; Koster MP
    Ned Tijdschr Geneeskd; 2015; 159():A8043. PubMed ID: 25761289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
    Shi X; He J; Lin M; Liu C; Yan B; Song H; Wang C; Xiao F; Huang P; Wang L; Li Z; Huang Y; Zhang M; Chen CS; Obst K; Li W; Yang S; Yao G; Li X
    Am Heart J; 2021 Aug; 238():45-58. PubMed ID: 33957103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in diabetes.
    Zhang PY
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2205-14. PubMed ID: 25070828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.